Ignite Creation Date:
2025-12-24 @ 11:05 PM
Ignite Modification Date:
2025-12-25 @ 8:36 PM
Study NCT ID:
NCT06462469
Status:
RECRUITING
Last Update Posted:
2025-11-25
First Post:
2024-06-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-04
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02-17
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-05
First Submit QC Date:
None
Study First Post Date:
2024-06-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-23
Last Update Post Date:
2025-11-25
Last Update Post Date Type:
ESTIMATED